The "Europe Sepsis Diagnostics Market Forecast to 2028 COVID-19 Impact and Regional Analysis By Product, Technology, Method, Test Type, Pathogen, and End User" report has been added to ResearchAndMarkets.com's
/PRNewswire/ Immunexpress, Pty Ltd., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced today the launch.
/PRNewswire/ Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced that SeptiCyte®.